Published ahead of print on April 17, 2008, doi:10.1164/rccm.200711-1637OC Am. J. Respir. Crit. Care Med., Volume 178, Number 1, July 2008, 26-33 A more recent version of this article appeared on July 1, 2008
Submitted on November 6, 2007 Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care UnitScot T Bateman1*,1 University of Massachusetts Medical Center, Worcester, MA, USA, 2 CHU Sainte-Justine, Montreal, PQ, Canada, 3 Research and Development, Johnson and Johnson Pharmaceutical, Raritan, NJ, USA, 4 Children's Hospital, Boston, MA, USA, 5 Children's Hospital of Saint Francis, Tulsa, OK, USA, 6 Penn State Children's Hospital, Hershey, PA, USA, 7 Children's National Medical Center, Washington, DC, USA, 8 Childrens Hospital of Los Angeles, Los Angeles, CA, USA, 9 Novo Nordisk Inc., Princeton, NJ, USA, 10 Children's Hospital and Research Center Oakland, Oakland, CA, USA * To whom correspondence should be addressed. E-mail: batemans{at}ummhc.org.
Rationale: Minimizing exposure of children to blood products is desirable.
Objective: We aimed to understand anemia development, blood loss, and red blood cell (RBC) transfusions in the Pediatric Intensive Care Unit (PICU).
Methods: Prospective, multi-center, 6 month observational study in 30 PICUs. Data were collected on consecutive children (<18 years old) in the PICU Key words: blood loss, anemia, transfusions, pediatric, intensive care
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||